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ABSTRACT 
The present study describes the preparation of extracellular matrix (ECM) based composite 
films, porous scaffolds, nanofibers and alginate beads for tissue engineering applications. The 
porous ECM-chitosan composite scaffolds were fabricated by freeze drying method for large soft 
tissue defects. The ECM composite injectable micro-beads were prepared by incorporating ECM 
within alginate by aid of centrifugal force for soft tissue engineering application. The ECM 
composite films were prepared by varying the ECM concentration in sodium alginate and 
chitosan for by solvent casting method for development of wound dressing materials. The ECM-
PVA, ECM-chitosan-PVA composite electrospun fibers were fabricated using free surface 
electrospinning technique for use in tissue engineering applications. The interactions amongst the 
composites were analyzed by FTIR and XRD studies. It was noticed that the porous scaffold 
were bio-compatible and with increase in chitosan content the pore size decreased as observed in 
electron microscope. The injectable microbeads can be fabricated using a 250 µm diameter 
needle at 1000 rpm in bucket centrifuge, with 3 % alginate and 100 mM of calcium chloride with 
0.1 % tween 80 as surfactant to reduce the coalescence of the formed beads. The films were 
thoroughly characterized for surface hydrophilicity, moisture retention capability, water vapor 
permeability, mechanical and biocompatibility. The mechanical properties suggested that the 
composite films had sufficient properties to be used for wound dressing applications. The ECM 
composite based electrospun fibers were formed at a working distance of 16cm and a working 
voltage of greater than or equal to 55 kV. It was noticed that with 10% PVA, and ECM 
concentration of 100mg/mL, with 0.02% SDS it was electrospinnable and the average fiber 
thickness was found to be 198±28 nm. With incorporation of chitosan, the ECM-PVA-chitosan 
solution was electrospinnable in 0.5M acetic acid and the average fiber thickness was found to be 
356 ± 65 nm. Thus the ECM was successfully electrospun with the incorporation of chitosan and 
PVA to enhance the electrospinnablity of the ECM for development of ECM composite 
electrospun fiber for tissue engineering application. 
Keywords: Human adipose tissue derived extracellular matrix, chitosan, alginate, microbeads, 
films, porous scaffold, free surface electrospinning, soft tissue engineering applications. 
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In the last decade, there has been an increase in the research on wound dressings. Wound is often 
described as a dynamic biosynthetic environment where a number of biological activities happen 
for the restoration of the loss tissues. Due to the occurrence of different biosynthetic reactions at 
the same time at the wound site, wound healing is often considered as a complex process. The 
wound healing process involves inflammation, cell proliferation and tissue remodeling[1]. The 
wound dressings may be broadly classified as the dry and wet wound dressings. Wet dressings 
have been found to be better suited for sustaining and even promoting the biosynthetic activities 
at the wound surface as compared to the dry dressings. [2] cell proliferation, accelerate 
angiogenesis, and facilitate cellular migration and epithelialization. 
This helps in enhanced wound healing rate. Because of these reasons, one of the important 
applications of wet dressings is its use in chronic wounds. The wet wound dressings are basically 
polymeric architectures which have the capability to imbibe and retain [3] ECM and chitosan has 
received much attention as a wound dressing materials due their excellent wound healing 
capabilities. 
Xenogenic ECM may be described as the combination of different extracellular proteins obtained 
from animal tissues (e.g. dermal, sub-mucosal and urinary bladder tissues of either bovine or 
porcine . The major components of ECM include collagen, elastin and glycosaminoglycans and 
supplementation of these important extracellular proteins from outside accelerate the wound 
healing by remodeling the tissue and acting as sacrificial template [4].   Additionally, ECM also 
contains various growth factors which enhance tissue repair by modulating the inflammatory 
response and promoting cell proliferation and migration [5-7]. 
Chitosan is a naturally occurring biodegradable polysaccharide [8]. N-acetyl-d-glucosamine, one 
of the biodegradation products of chitosan, has been found to promote fibroblast proliferation 
which helps in wound contraction and early stage of wound healing process. The anti-
inflammatory, hemostasis and anti-bacterial property of chitosan has been found to be useful in 
reducing pain and preventing wound infections, thereby, indirectly helping in wound healing rate 
[9]. The properties of the chitosan wound dressings may further be improved by preparing 
chitosan based composite gels, films and scaffolds. The composite may be prepared using 
collagen [10], hyaluronic acid [11], silk fibroin and alginate dialdehyde [12], gelatin [13] and 
heparin. 
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OBJECTIVES: 
 To fabricate and characterize porous scaffolds for large soft tissue defects  
 To fabricate and characterize injectable microbeads for soft tissue/cosmetic engineering  
 To prepare and characterize composite films for wound dressing material  
 To fabricate and characterize electrospun nanofibrous scaffolds   
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2.1 CHITOSAN POROUS SCAFFOLDS:  
The Porous chitosan scaffolds obtained from freeze drying process. The pore size will vary 
depends on freezing conditions[14]. The tensile strength of non porous chitosan is more than 10 
times of porous chitosan, but the extensible property is twice less than porous chitosan . 
Tarun garg et.al., dissolve the chitosan solution in 0.2 M glacial acetic acid and stored at room 
temperature for one day. Later, poured into stainless steel mould and kept in deep freezer at -
70°C for 5 days. After that 5 days, mould was kept in lyophilise (Martin Christ alpha 1-2 LS 
plus, Germany) for 3 days. 
 
In the lyophiliser, faced the 3 phases of preparation. First phase: freezing phase (sample was 
exposed up -40°C) for 10 min. Second phase: warm up vacuum pump phase (sample was 
exposed to -15°C) for 20 min. Third phase: drying phase (sample was exposed to 30°C) for 3 
days. By following the these 3 phases, porous chitosan scaffolds can be prepared.[2] 
 
Nitar New et.al. compared the biological and mechanical properties among the fungal chitosan 
scaffolds, chitosans which are obtained from shrimp and crab shells and squid bone plates. 
Diameter 60-90 μm observed in these scaffolds. Elongated pores observed in shrimp scaffolds 
but polygonal pores observed in chitosan scaffolds. Shrimp scaffolds showed that the lowest 
water absorption and lysozyme degradation rate whereas the fungal chitosan scaffolds showed 
extremely good mechanical strength, water absorption and degradation properties. The 
proliferation of fibroblast NIH/3T3 cells was faster with polygonal morphology on crab, squid 
and fungal chitosan scaffolds than shrimp chitosan. Its revealed that the fungal chitosan scaffold 
is the most suitable scaffold to use as a template for tissue regeneration.[3]Chitosan/gelatin 
prepared through formation of  polyelectrolyte complex, freeze drying and post – crosslinking 
with glutaraldehyde. The pore diameters depends on the original water content and freezing 
conditions [4]. Chitosan porous scaffolds fabricated by freeze gelation method, the tensile 
strength and strain increased significantly in higher freezing and (1-2M) acetic acid concentration 
at maximum load, whereas rinse buffer with 95% ethanol concentration, tensile strength slightly 
increased. Crosslinking with the glutaraldehyde (GTA), enhances the tensile strength. The dose 
response was not observed by crosslinking with EDC and TPP [5]. 
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Natural biodegradable polymers were processed by different techniques like novel solvent –
exchange phase separation technique and thermally induced phase separation method to produce 
porous structures. [15].  
2.2 SODIUM ALGINATE BEADS: 
Alginate hydrogels extracellular matrix-like features have been key for cell delivery strategies in 
tissue regeneration [7]. The microbeads with simvastatin loading prepared by ionotropic gelation 
and cross linking technique using alginate as the hydrophilic carrier and calcium chloride as 
cross linking agent[16]. 
The blue dextran release from alginate gel beads was affected by the ratio of drying time and 
blue dextran/sodium alginate but not by the alginate concentration, calcium chloride 
concentration. The drug release was more rapid at pH 1.2 than pH 6.8.[9] 
The applications of sodium alginate gel for encapsulation, immobilization of variety of cells and 
forms biodegradable gel when cross linked with calcium ions. Alginate as a substrate for cell 
proliferation until when RGD is modified. The mechanical property found high purity and high 
G-type alginate retained 27 % of its initial strength.[10] 
The sodium alginate concentration has no effect on the release of drug like sulphamethoxazole, 
the release was found to be a function of calcium chloride concentration. The lower the release, 
the higher the concentration and smaller the water content [11]. 
 
2.3 CHITOSAN FILMS: 
Chitosan films with 3 molecular weights and 4 organic acid solvents, tensile strength increased 
with chitosan molecular weight [12].Chitosan has a great potential for a wide range of 
applications due to its biodegradability, biocompatibility, antimicrobial activity, non-toxicity and 
versatile chemical and physical properties. Thus, chitosan based films have proven to be very 
effective in food preservation. The presence of amino group in C2 position of chitosan provides 
major functionality towards biotechnological needs, particularly, in food applications. Chitosan 
based polymeric materials can be formed into fibres, films, gels, sponges, beads or even 
nanoparticles [13]. 
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In the chitosan films, degree of deacetylation and molecular weight affects the film properties of 
physicochemical. Higher the degree of deacetylation, [17]The antimicrobial and 
physicochemical properties of chitosan films, enhanced with essential oils (EO) , was determined 
invitro, showed that the antibacterial effects of the EO when incorporated in the films. The 
potency of antimicrobial efficacy was in order of oregano > coriander > basil > anise. With the 
addition of EO to chitosan films decreased tensile strength, water vapour permeability and 
increased in elasticity of the films. 
2.4 USEFULNESS OF CURCUMIN: 
Curcumin is an antibacterial pigment which is yellow in colour obtained from turmeric, rhizomes 
of curcuma longa linn (Zingiberaceae), used in medicine for the treatment of inflammatory 
conditions. [14] 
It exhibits biological properties, anti-inflammatory, anticarcinogenic activies, hepato and 
nephron protective, regulates various [18]. 
2.5 USEFULNESS OF EXTRA CELLULAR MATRIX (ECM): 
Extra cellular matrix is an acellular component present around the cells, which gives mechanical 
support for the cells, helps in cellular behaviours including proliferation, survival, migration and 
differentiation which leads to the development of cells in the tissue, possess role in signalling 
pathways. [11] 
Four major classes of macromolecules—collagens, Glycosaminoglycans, proteoglycans, and 
elastin collectively comprise the ECM of mammalian cells, being both widely distributed and 
multifunctional throughout the body. The different types of collagen proteins available in ECM 
to form heterotypic fibrils to [19]. . 
ECM based material scaffolds are highly compatible with tissue, possess mechanical strength 
which influences the cellular proliferation and cell differentiation. From the urinary bladder 
matrix, ECM strongly affect the smooth muscle cells phenotype, differentiation.[56] Both the 
tissue and  scaffold possess similar compliance and should contain same mechanical property of 
target tissue, otherwise, it may leads to failure invivo. 
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3.1 MATERIALS: 
Acetic acid was purchased from Loba Chemie Pvt. Ltd., Mumbai, India. Chitosan (Degree of 
deacetylation >75%), Sodium acetate trihydrate, Chloramin T trihydrate, Dulbecco’s modified 
eagle medium (DMEM), Nutrient Broth and Fetal bovine serum (FBS) were procured from 
Himedia Lab. Pvt. Ltd., Mumbai, India. Citric Acid Monohydrate was purchased from SRL Ltd., 
Mumbai, India and 4-Dimethylaminobenzaldehyde was supplied by Merck Specialties Pvt. Ltd., 
Mumbai, India. Sodium Alginate was purchased from S.D.Fine – Chem. Ltd.  
 
The Adipose derived stem cell line was procured from NCCS, Pune. All other chemicals used 
were of analytical grade and were obtained locally. The decllularized tissue frozen at -80⁰C for 
24hr and were lyophilized in a freeze-dryer (Operon Chemical free freeze dryer-120C). 
 
3.2 METHODS: 
3.2.1 DECELLULARIZATION OF ADIPOSE TISSUE: 
The seared portions parts of the gathered adipose tissue were discard and the tissue washed in 
refined water for 3-4 times to evacuate the blood segments. The washed fat tisuue blended with 
twofold volume of refined water and homogenized in house hold blender for 5min with throb in 
at regular intervals. The oil removed out from the cells amid homogenization was isolated by 
centrifuging the suspension at 3000g for 5 min at room temperature. The upper oil layer and 
lower water rich layer tossed and the center layer containing fat tissue and ECM put away for 
further handling. The specimen after mechanical decellularization (homogenization), treated with 
freeze thawing method. The sample subjected to 15 cycles of stop defrosting (-20⁰C- 37⁰C), oil 
ousted after every cycles was evacuated by centrifugation at 3,000g for 5 min. After the freeze-
thawing the samples were treated with anionic cleanser sodium dodecyl sulfate (SDS) to remove 
the oil substance furthermore help to break the plasma film and atomic layer in this way will help 
to content the immunogenic component DNA[20] The ECM blended in 0.5% SDS solution for 
1h at room temperature. The SDS confine inside the ECM was evacuated by perpetual washing 
in distilled water for 24h at 4⁰C with a water substitution in 2hr gap. The decellularized tissue 
was then solubilized in 0.5 M acetic acid solution under unterrupted stirring for 48 hours. The 
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arrangement was then sifted through muslin fabric and centrifuged again at 8000 rpm for 10 min 
to get absolute ECM. The ECM was then put away at 4°C for further utilize. 
 
Figure – 3.1: Decellularization of adipose tissue 
3.2.2 PREPARATION OF POLYMER-ECM COMPOSITE FILMS: 
3.2.2.1 CHITOSAN-ECM COMPOSITE FILMS: 
2% chitosan (Degree of deacetylation > 75%) solution was arranged in 0.5 M acetic acid solution 
under mixing condition. 2% alginate solution was arranged in distilled water. For which, 2gm 
sodium alginate powder was gradually added to distilled water under mixing condition. A 
Homogenous arrangement was arranged through a consistent and overnight blending. On other 
hand, the ECM pellet got after decellularization of omentum tissue, was lyophilized to uproot the 
water content from ECM pellet. From that point, lyophilized ECM was broken up in 0.5M acetic 
acid solution for get a definite concentration of 50 mg/ml, 100 mg/ml and 150 mg/ml. From there 
on, Chitosan and ECM solution (all fixations), were blended in 6:4 (w/w) proportion under 
blending conditions took after by degassing[21]. The chitosan-ECM composite films were 
prepared utilizing solvent evaporation technique as depicted by Maryam Koucha et al. 30g each 
Human Adipose tissue Washing & tissue homogenization Centrifugations 
Repeated freeze (-20⁰C) 
thawing (37⁰C)
Solubilized in 0.5M acetic acid + 
After washing 0.5% SDS treatment
Decellularized tissue
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of prepared Chitosan-ECM arrangements were poured in the 90mm petri dish and dried for 48 
hours in the vacuum oven (Q5247, Navyug, India) at 37°C. The dried composite films were 
extracted from petri dish utilizing 2N sodium hydroxide treatment for 30 minutes. From there on, 
the films were peeled out, washed 3-4 times with refined water and kept for drying at 37°C for 
around 24 hours. 
3.2.2.2 CHITOSAN-CURCUMIN COMPOSITE FILMS: 
2% chitosan (Degree of deacetylation > 75%) solution was arranged in 0.1 M acetic acid solution 
under stirring condition. A homogenous solution was arranged through a consistent 4 hours 
mixing. On the other hand, weigh the curcumin at different concentrations in 10 mg, 50 mg and 
100 mg. Dissolve the curcumin in chitosan solutions by using ethanol to dissolve uniformly, with 
stirrer. Keep the beakers in dessicator for overnight to avoid air bubbles while pouring in 
petriplates. Cascade the chitosan solutions in petriplates after wiping with paraffin oil without air 
bubbles, such that one control, 10 mg, 50 mg, 100 mg of curcumin with films. The chitosan-
curcumin composite films were concoct utilizing solvent evaporation technique as depicted by 
Maryam Koucha et al. 30 gm each of prepared Chitosan-curcumin solutions were poured in the 
90mm petri dish and dried for 48 hours in the vacuum oven (Q5247, Navyug, India) at 37°C[22]. 
 
Figure 3.2 – Chitosan-ECM composite film 
3.2.2.3 CHITOSAN-CURCUMIN COMPOSITE FILMS WITH GLYCEROL: 
0.5% glycerol solution was prepared before adding chitosan, such that glycerol will be 
solubilized with chitosan more uniformly. The 2% chitosan is gradually added to distilled water 
under mixing condition. A homogeneous solution was prepared through a consistent and 4 hours 
blending. On the other hand, weigh the curcumin at different concentrations in 10 mg, 50 mg and 
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100 mg. Dissolve the curcumin in chitosan solutions by using ethanol to dissolve uniformly, with 
stirrer. The polymer solution with glycerol blended took after by degassing. 30 gm each of 
prepared Chitosan-curcumin solutions were poured in the 90mm petri dish and dried for 48 hours 
in the vacuum oven (Q5247, Navyug, India) at 37°C. The dried composite films were extracted 
from petri dish utilizing 2N sodium hydroxide treatment for 30 minutes. From there on, the films 
were peeled out, washed 3-4 times with refined water and kept for drying at 37°C for around 48 
hours treatment for 30 minutes. From there on, the movies were peeled out, washed 3-4 times 
with refined water and kept for drying at 37°C for around 24 hours.  
3.2.2.4 ALGINATE-CHITOSAN-ECM COMPOSITE FILMS: 
2% chitosan solution was prepared in 0.1 M acetic acid solution under stirring condition along 
with 150 mg of ECM. A homogeneous solution was prepared through a consistent 4 hours 
blending. On the other hand, 2 % alginate solution prepared with distilled water. Keep the 
beakers in dessicator for overnight to avoid air bubbles while pouring in petriplates. 15 gm of 
alginate solution were poured in the 90 mm petri dish and leave for 12 hours in vacuum oven 
(Q5247, Navyug, India) at 37°C. After 12 hours, 15 gm of chitosan solution with ECM poured 
over the layer of alginate film in petri dish and dried for 48 hours in vacuum oven, such that the 
crosslinking impact will be more. Along with these films, the control films of each 30 gm also 
prepared of alginate, chitosan, and alginate chitosan composite films[23]. 
 
Figure 3.3 – Layer by layer approach to fabricate polyelectrolyte ECM composite films 
 
SODIUM ALGINATE 
LAYER
CHITOSAN ECM 
LAYER
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3.2.3 PREPARATION OF ALGINATE-ECM COMPOSITE MICROBEADS: 
2 % alginate solution was prepared with 1 mg/ml of ECM in distilled water under stirring 
condition. For formation of specific size of beads, prepared 100 mM of calcium chloride solution 
was added with 0.1% of tween 80 to reduce the random size of beads. The beads were performed 
by falcon tubes centrifugation through bucket centrifuge with needle and syringe. The setup was 
arranged by inserting syringe in falcon tube in such a way that there should be a gap between 
needle and calcium chloride solution. Centrifugation was carried out in 1000 rpm to execute best 
beads without any tailor cones[24]. 
 
Figure 3.4 - A) Falcon tube with needle B) Bucket Centrifuge 
3.2.4 PREPARATION OF CHITOSAN-ECM POROUS SCAFFOLD: 
ECM was blended with distilled water, 0.1 % chitosan is gradually added. On the other hand, the 
other ECM with 1% chitosan is prepared. The prepared solution fabricated into 3 dimensional 
scaffolds with a certain mould with freeze drying method.  
 
Figure 3.5 – Freeze dried porous scaffold with mould 
A B
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3.2.5 PREPARATION OF ELECTROSPUN ECM COMPOSITES: 
2 % chitosan solution was prepared in 0.5 M acetic acid solution. On the other hand, 100 mg/ml 
of ECM solution was prepared in distilled water with 10 % polyvinyl acrylamide. Both the 
solutions were mixed in ratio of 30:70 with ECM PVA solution and chitosan respectively. 
Electrospinning was carried out in Roller Electrode Electrospinning or free surface 
electrospinning[25]. 
3.2.6 CHARACTERIZATION OF ECM COMPOSITES: 
3.2.6.1 MECHANICAL TESTING OF FILMS: 
The mechanical properties of the Chitosan ECM films, chitosan curcumin films and alginate 
chitosan ECM composite films were analyzed using stress relaxation and creep recovery studies. 
The tests were conducted using a static mechanical tester (TA-HD plus Texture Analyzer, Stable 
Micro Systems, UK). The films were cut into rectangular pieces of size 5 mm x 60 mm. The 
films were held using tensile grip attachment such that the length between the probes was 50 mm 
(effective length). For the stress relaxation study, the films were stretched by 1 mm after a trigger 
force of 5 g. The relaxation study was conducted for a period of 60 s. The creep study was 
conducted by applying a force of 50 g during the creep phase and subsequently applying a force 
of 5 g during the recovery phase. The mechanical testing was done using the two models as 
discussed in the Figure 3.6, with the various parameters discussed in the results and discussions 
section. 
 
Figure 3.6 - Mechanical testing models -a) Weichert Model, b) Burger’s model 
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3.2.6.2 X-RAY DIFFRACTION: 
The prepared composites were analyzed using X-ray diffractometer (PW3040, XRD-
PANalytical, Philips, Holland). Cu – Kα radiation (0.154 nm) was performed. The instrument 
was operated at 30 kV and 20 mA. Scanning of the films was done at 5° - 50° 2θ at a rate of 2° 
2θ /min, porous scaffolds was done at 5° - 40° at a rate of 5° 2θ /min, and the beads was done at 
5° - 45° at a rate pf 5° 2θ /min. The analysis was performed at the room-temperature.  
The crystallinity index (CrI) of the films was calculated from the diffractograms using following 
equation: 
21 16
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where, I21 is the intensity of peak at  21° 2θ; and I16 is the intensity of the amorphous valley peak 
at  16° 2θ. 
3.2.6.3 FOURIER TRANSFORM INFRARED SPECTROSCOPY: 
The prepared composites were analyzed using FTIR spectroscope to understand the interaction 
The spectroscope was operated in the ATR mode (Alpha-E, Bruker, Germany). Scanning was 
done in the wavenumber range of 4000 cm-1 to 500 cm-1. 
3.2.6.4 SURFACE HYDROPHILILICITY: 
The surface hydrophilicity of the chitosan ECM films was measured using the sessile drop 
method. Drop of water was placed on the rectangular pieces of the composites and the contact 
angles were obtained using drop shape analyzer (DSA 25 Kruss Germany).  
 
3.2.6.5 MOISTURE ABSORPTION TEST: 
For the moisture absorption tests, the films were cut into pieces of 1 cm x 1 cm and subsequently 
dried in a vacuum drying oven for 24h. The films were weighed and then transferred to a 
desiccator, maintained at 84% humidity using saturated solution of potassium chloride, for 12h. 
The final weight of the films was noted. The percentage of moisture absorbed was calculated 
using equation: 
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where, %M= Percentage of moisture absorbed, Wi= Initial weight of the films; and Wf = Final 
weight of the films after incubating in the desiccator. 
3.2.6.6 WATER VAPOR TRANSMISSION TEST: 
Water vapor transmission of the films was evaluated as per the ASTME 96 standard. In brief, the 
chitosan ECM composite films and chitosan alginate ECM films were kept completely adhered 
on the top of the cylindrical glass tubes (volume = 71.42 cm3) using a Teflon tape (P.T.F.E. 
Thread Seal Tape). The arrangement of the complete setup has been illustrated in Fig. S1. Each 
tube was initially filled with preweighed (30 ml) PBS. The initial weight and height of the water 
(from base) was recorded and then the tubes were kept at 37 °C. The readings were taken at 
regular intervals of 2 days for two weeks. The transmission of water vapor through the films was 
calculated using following equation: 
                                                  2 1
B B
WVTR A
t

       
where, WVTR=Water vapor transmission rate (g/day-m2); B2= Final weight of the set-up; B1= 
Initial weight of the set-up; t= Time (days); and A= Effective area of evaporation. 
 
3.2.6.7 CURCUMIN RELEASE KINETICS: 
The polymer – curcumin composite films were analyzed for the drug release kinetics. The films 
were placed in a PBS solution and covered with dialysis membrane. The constant volume of PBS 
was taken at regular intervals of time of 15 min, 30 min, 45 min, 1 hr, 2 hr, 3 hr, 4 hr, 5 hr, 6 hr, 
8 hr, 12 hr, 24 hr, 48 hr, 72 hr, 96 hr, 120 hr, and 144 hr. While taking the readings each time, the 
volume was maintained constant by replacing it with fresh PBS such that to add cumulatively 
from time to time. The absorbance of all the samples was taken at 430 nm [150]. 
3.2.6.8 CONFOCAL MICROSCOPY:  
The presence of ECM in the micro-bead composites were found using the dye ANS (8-Annilino-
napthalene sulfate), which detects the surface hydrophobicity of the proteins. Using Leica TCS 
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SP8 confocal microscope, the ANS dye was incubated with beads and with an excitation of 
390nm the presence of protein was detected. 
 
3.2.6.9 SCANNING ELECTRON MICROSCOPY OF POROUS SCAFFOLD: 
Scanning Electron Microscopy (SEM) was performed utilizing a JEOL-JSM 6480 LV to discern 
the morphology of chitosan ECM porous composite scaffolds, alginate beads, electrospinned 
fibers at both cross-segment and longitude-area. Platinum covering was done preceding imaging. 
3.2.6.10 HEMOCOMPATIBILITY TEST: 
For hemocompatability studies of chitosan curcumin composite films, the fresh goat blood was 
taken and diluted in 1:1 ratio with 0.9 % normal saline and 0.5 ml of dilute blood. The dried 
films cut in size (1*1cm2) placed in saline for 1 hr. After taking of diluted blood with saline and 
blood in 5:4 ratio respectively, for making of positive control, add 0.5 ml of blood and make upto 
10 ml of saline. For negative control, add 0.5 ml of 0.01N HCL and make upto 10 ml with saline. 
The percentage of hemolysis can be calculated by using the formula. 
                             
Z % = ((Dt-Dnc)/ (Dpc-Dnc))*100 
 
Where, Dt = test OD, Dnc = OD of negative control, Dpc= OD of positive control. If the 
percentage is more than 5, it is haemolytic. If 2 to 5 it is slightly haemolytic and if it is found 
between 0 to 2 non-hemolytic in nature. 
 
3.2.6.11 IN-VITRO CYTOTOXICITY TESTS: 
The ability of the chitosan ECM composite films, chitosan curcumin films, Alginate chitosan 
ECM composite films, porous scaffolds and sodium alginate beads to support the proliferation of 
the human subcutaneous adipose tissue derived stem cells (ADSCs) was evaluated in vitro. The 
ADSCs were procured from Himedia Pvt. Ltd. Mumbai, India after Institute ethical clearance. 
The cells were maintained in Dulbecco’s Modiﬁed Eagle Medium (DMEM) with 10% Fetal 
Bovine Serum (FBS) at 37 °C (5% CO2 and 95% humidity)[26]. The media was replaced every 
72h.When the cells reached 80% confluency, they were harvested with 0.05% trypsin/EDTA 
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solution. Subsequently, the cells were seeded at a cell concentration of (1 x 104) cells/ml onto 24 
well plates. After 24h of incubation, the status of cell adherence were evaluated and ethanol 
sterilized film samples (1cm x 1cm) were added into the wells. The metabolic activity of cells 
was monitored using MTT assay after 48h of incubation .The assays were done in quadruplet for 
each sample. 
 
3.3 STATISTICAL ANALYSIS: 
The statistical analysis of the experimental data was carried out by unpaired t-test and one – way 
ANOVA using IBM SPSS Statistics 20.0. The p values of ≤0.05 were considered to be 
statistically significant. 
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RESULTS AND 
DISCUSSION 
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4.1 PREPARATION AND CHARACTERIZATION OF COMPOSITE FILMS: 
4.1.1 CHARACTERIZATION ECM-CHITOSAN FILMS: 
The ECM was incorporated within the chitosan films so as to accelerate the wound healing 
process. It was expected that the presence of collagen, elastin and glycosaminoglycans might 
enhance the rate of wound healing. Also, it was expected that the ECM derived from the 
omentum might be a rich source of growth factors due to the high vascularization of the 
omentum tissue. Apart from the above, during the extraction of the ECM, it was observed that a 
very good proportion of ECM was extracted using a relatively simple process of combination of 
mechanical thermal and chemical methods. The prepared films were light brown in color. This 
was mainly due to the color of the chitosan. The films were translucent in nature. The total 
collagen content of the digests was determined using the relationship that hydroxyproline forms 
14.3% of total collagen. The extracted collagen contents of the omentum derived ECM was 
determined to be 0.78 ± 0.07 mg of collagen per mg of initial dry weight. 
4.1.1.1 MECHANICAL ANALYSIS OF ECM-CHITOSAN COMPOSITE FILMS: 
The mechanical properties of the films were analyzed by conducting stress relaxation and creep-
recovery studies. During the loading phase of the stress relaxation study (as seen in Figure 4.1), 
the force was monotonously increased till the end of the loading phase. Thereafter, there was a 
decrease in the force to a residual value due to the molecular rearrangement of the polymeric 
chains in the films. The maximum force at the end of the loading phase is regarded as F0, which 
provides the information about the firmness of the films. It was observed that the incorporation 
of ECM resulted in the decrease in the firmness of the films. Amongst the ECM containing films, 
there was an initial decrease in the firmness of the films when the ECM content was increased 
from CE50 to CE100. Thereafter, a further increase in the ECM content resulted in the increase 
in the firmness of the films. D300 was calculated to have an understanding on the ductility of the 
films. D300 is defined as the distance moved by the probe to attain a 300 g force. From the results 
(Table 4.1), it was seen that the ductility of CE100 was highest. 
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Table 4.1 - Mechanical properties of the films based on stress relaxation studies 
 
 
Figure 4.1 - (a) Stress relaxation profiles; (b) Stress relaxation curves after fitting to the 
modified Peleg’s equation; (c-f) Weichert model fitting curves to the stress relaxation profiles. 
 
For a composite film to be used as a wound dressing material, the ductility of the material is an 
important criterion. Hence, it is expected that CE100 might be a comparatively efficient film for 
wound dressing. The trend of the residual force (Fr) of the films was same as that of the 
maximum force during the loading phase. The residual force is an indicator of the energy stored 
in the films after the relaxation process. From the maximum loading force and the residual force, 
percent relaxation (%SR) was calculated. It was observed that the %SR was highest in the 
Sample Un-normalized curve Normalized Curve 
F0 Fr %relaxation D300 K1 K2 R2 
CC 676.2  302.0 55.3 0.31 0.01 -0.038 0.998 
CE50 530.6 301.0 43.2 0.27 0.01 -0.057 0.996 
CE100 373.4 255.3 31.6 0.40 0.01 -0.061 0.996 
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control. Amongst the ECM containing films, the %SR was highest in CE50. The %SR of CE100 
and CE150 was nearly equal. Higher stress relaxation values of control and CE50 suggested that 
these films were having higher viscoelastic fluid nature. In other words, the viscoelastic solid 
component was predominant in CE100 and CE150. 
The viscoelastic property of the films was predicted using modified Peleg’s equation [26]. The 
constants K1 and K2 are the indicators of initial rate of relaxation and the extent of relaxation, 
respectively. The K1 values of all the films were similar. This suggested that the initial rate of 
relaxation was nearly equal in all the films. The K2 values were found to be lower in the films 
with higher proportion of ECM. This observation is in accordance to the %SR values obtained 
from the stress relaxation profile. The Peleg’s equation is given as follows: 
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Unfortunately, the Peleg’s model also failed to explain the viscoelastic properties of the films in-
depth. Hence Weichert mechanical model (Figure 4.2) for viscoelasticity was used for predicting 
the viscoelastic behavior of the films. The Weichert model is the most commonly used model for 
understanding the viscoelastic property of soft materials. The experimental data were fitted to the 
Weichert model by non-linear least square sum of difference method. The correlation coefficient 
between the experimental data and the fitted data was >0.98. This suggested a close match 
between the experimental and the fitted data.  P0 provides information about the modulus of 
elasticity of the Hookean spring in the Weichert model. This factor provides information about 
the inherent elasticity of the viscoelastic materials. It was found that there was an increase in the 
P0 values when the ECM content was increased from control to CE100. Thereafter, there was a 
slight reduction in the P0 value in CE150. These results are in accordance with the %SR values 
where it was observed that the %SR was lowest in CE100, which indicates that the elastic 
component of CE100 was higher. The P1 value indicates the initial elastic value during the 
relaxation process. A decrease in the P1 values was observed with the increase in the ECM 
content. The P1 values of CE100 and CE150 was equal. τ1 value was increased with the increase 
in the ECM content till CE100. Subsequently, a further increase in the ECM content in CE150 
resulted in the decrease in the τ1 value. τ1 value is a marker of the initial relaxation time during 
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the relaxation process. This suggested that the relaxation process in CE100 was slowest and may 
be accounted to the interaction of the proteins molecules present in the ECM with the chitosan 
molecules. The τ2 values also followed the same trend as that of τ1. τ3 showed an increase in the 
relaxation time with the increase in the ECM content. τ2 is an indicator of the intermediate 
relaxation process, whereas, τ3 is a marker of the relaxation process happening at longer period 
of time after the load has been applied. The occurrence of the intermediate (τ2) and the delayed 
(τ3) relaxation time have been reported to be associated with the breakage of the polymer-
polymer interactions in the films. The analysis of τ2 and τ3 suggested that the breakage of the 
polymer-polymer interactions was much lower in CE100. Hence, it is expected that CE100 might 
maintain its integrity in case of sudden accidental stress being applied. 
 
Figure 4.2 - (a) Creep recovery profiles of the films; (b-e) Burger’s model fitting curves to the 
creep data and (f) % recovery of the films. 
The creep study (Figure 4.2) is associated with the application of a constant load for a particular 
period of time. The cumulative strain developed during this period is recorded. This gives 
information about the ability of the films to undergo molecular rearrangement when a constant 
force is applied. The analysis of the creep data was done by fitting the experimental data to the 
eight-element Burger’s model.  
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Table 4.2 - Mechanical properties of the films based on creep studies 
Sample ᶯ0 ᶯ1 ᶯ2 ᶯ3 
CC 3.12E+09 343.2282 8.176258 5505.177 
CE50 3.11E+09 329.2308 7.114436 13102.45 
CE100 3.11E+09 371.0418 8.262875 15435.28 
CE150 3.11E+09 373.3812 9.775125 28386.88 
 
In many cases, it has been seen that either four-element or six-element Burger’s model is 
sufficient to model the creep properties of the soft materials. But in this case, an eight element 
Burger’s model was needed to efficiently model the creep data. The instantaneous elasticity (E0) 
was found to be higher in ECM containing films. This indicated that the addition of ECM to the 
chitosan matrix helps improving the instantaneous elastic component of the chitosan films. The 
initial elastic (E1) and the intermediate elastic (E2) components, during the loading phase, also 
showed a similar trend, i.e., an increase in the elastic component with the increase in the ECM. 
On the contrary, the delayed elastic component (E3) showed a reverse trend. The initial and the 
intermediate relaxation time of the control film were higher than the ECM containing films. 
Amongst the ECM containing films, both the initial and the intermediate relaxation times 
initially decreased with the initial increase in the ECM content in CE100. A further increase in 
the ECM content increased the relaxation time. The delayed relaxation time was found to be 
higher in the films with higher ECM content. An increase in the delayed relaxation time with the 
ECM content suggested that the incorporation of ECM in the chitosan matrix retarded the 
breakage of the polymer-polymer interactions. The percentage recovery of the ECM containing 
films was found to be higher in the films containing higher amount of ECM. This indicated that 
an increase in the ECM content might result in the increase in the viscoelastic fluid component. 
To have an insight on the viscous components of the dashpots of the Burger’s element was 
calculated. It was found that the instantaneous viscosity of the films were much higher. Except 
the instantaneous viscosity, the viscosity of the other dashpots (associated with the Kelvin-Voigt 
parts) showed an increase in the viscosity with the increase in the ECM content. 
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The %SR studies indicated that when an instantaneous stress is applied to CE100, the chances of 
breakdown of the polymer-polymer interactions are lower. On the contrary, the creep study 
suggested that when a constant load is applied on the films the chances of breakdown of the 
polymer-polymer interactions is lower in the films with higher ECM content. From the above, it 
can be concluded that CE100 might have sufficient properties to be used as wound dressing 
materials.  
4.1.1.2 XRD AND FTIR ANALYSIS OF THE ECM-CHITOSAN FILMS: 
 
Figure 4.3 – XRD and FTIR Spectrographs of ECM-Chitosan films 
The X- ray diffractograms of chitosan and the films have been shown in Figure 4.3. X’Pert High 
score (Version 1.0b, Philips analytical B.V) was used to analyze the diffractograms of the films. 
Chitosan has been reported to have diffraction peaks at ~10° and ~20° 2θ [27]. Collagen, a major 
constituent of ECM, shows a broad diffraction pattern at 10° 2θ along with a characteristic peak 
at 23° 2θ [28]. The typical peaks (12° 2θ and 21° 2θ) of chitosan were noticed in the composite 
films. A decrease in the intensity of the peak at 12° 2θ with the corresponding appearance of a 
new peak at 15° 2θ was observed in the chitosan films.  An increase in the crystallinity index 
(Table 4.3) was observed in CE50, which gradually decreased with the increase in the ECM in 
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the films (CE100 and CE150) as compared to the chitosan film (CC).Crystallinity of 
biopolymers plays important role in modulating their mechanical and biological properties. In 
general, with increase in crystallinity, tensile strength and stiffness increases and creep 
decreases. But increase in crystallinity also imparts anisotropy to a composite structure.  Increase 
in crystallinity is also been associated with lower inflammatory response and higher cell 
adhesion. 
Table 4.3: Crystallinity index of the films 
Samples Crystallinity index 
CC 0.28 
CE50 0.43 
CE100 0.36 
CE150 0.35 
 
The FTIR analysis was done to have an understanding about the chemical interactions amongst 
the components of the chitosan-ECM composite films. The major absorption peaks associated 
with the chitosan include 3428 cm-1 (N-H and O-H stretching), 2949 cm-1(CH3 symmetric 
stretching), 1663 cm-1 (C=O stretching vibrations), 1439 cm-1 (C–N stretching vibration), 1365 
cm-1 (CH3 bending vibration), 1134 cm
-1 (C–O–C bending vibration), and 1084 cm-1 (C–OH 
stretching vibration) [41]. As discussed above, ECM is mainly a mixture of various proteins. 
Hence, the FTIR spectra of ECM was expected to have amide I (1622 cm-1, 1630 cm-1, 1638 cm-
1, and  1644 cm-1), amide II (1552 cm-1, 1560 cm-1, and 1579 cm-1) and amide III (1259 cm-1) 
bands. These absorption peaks were also observed in the prepared films. Absense of any new 
charactereistic peaks suggested that there was no new bond formation and hence the interaction 
amongst the ECM and chitosan. 
 
4.1.1.3 SURFACE HYDROPHILLICITY: 
Contact angle measurement data (Fig. 4a) indicate that there is statistically significant increase in 
hydrophilicity of the ECM containing films compared to chitosan only film. Furthermore, CE50, 
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CE100 and CE150 have statistically significant difference in the contact angles signifies with 
increase in the concentration of ECM in chitosan film, the hydrophilicity keeps increasing. 
4.1.1.4 MOISTURE ABSORPTION: 
In concordance with the increasing hydrophilicity of composite films, the moisture absorption 
capacity of the films (Fig. 4b) was lower in the films which contained lower proportions of 
ECM. The differences in the absorbed moisture amongst the films were statistically significant. 
The components (e.g. collagen, elastin and glycosaminoglycans) of ECM are proven hydrophilic 
molecules. Hence, incorporation of ECM into the films resulted in the increase in the 
hydrophilicity of the films, which in turn, resulted in the absorption of higher amount of 
moisture. 
 
Figure 4.4 – a) Surface hydrophobicity, b) Moisture adsorption and c) water vapor transmission 
 
4.1.1.5 WATER VAPOR TRANSMISSION TEST: 
Water vapor transmission rate (WVTR) is regarded as the transmission of the water vapor per 
unit time through a unit area of the materials under test. The water vapor transmission rate (Fig. 
4c) was determined. The differences observed amongst the different groups were statistically 
significant. An increase in the ECM concentration resulted in the decrease in the WVTR. This 
can be explained by the increase in the hydrophilicity of the films when ECM was incorporated, 
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which resulted in the increase in the binding of the water molecules. This, in turn, resulted in the 
decrease in the permeability of the water vapor from the films.  
An ideal wound dressing should control the water loss at an optimal rate and keep the wound 
moist. The recommended rate of water loss in the form of vapor is 2000–2500 g/day-m2 [29]. 
This rate of evaporation is expected to keep the wound moist without getting dehydrated. The 
WVTR though the composite films falls within the recommended range indicating its suitability 
as better wound dressing material.   
 
4.1.1.6 IN VITRO CYTOTOXICITY TEST: 
 
Figure 4.5 – In vitro cytotoxcity test using MTT for chitosan-ECM films  
The in vitro cytocompatibility of the films was analyzed using the MTT assay (Figure 4.5). All 
the films were found to be cytocompatible. The chitosan film and the chitosan-ECM composite 
films showed statistically significant increase in cellular proliferation when compared to the cells 
grown on tissue culture plate (control). The chitosan film (CC) showed better cellular 
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proliferation as compared to the composite films. However, increasing the concentration of ECM 
in the composites, revealed no statistically significant increase in the cellular proliferation. The 
micrographs of the adipose derived stem cells indicate that the spreadability of individual cells in 
presence of composite films was higher than the chitosan film. The presence of protein 4.1 
superfamily in extracellular matrix is known to increase the spreadability of the cells through 
integrin family receptor binding and β-integrin mediated cell spreading [30]. The results 
indicated that the developed composite films were well suited for wound healing applications. 
 
4.1.2 CHARACTERIZATION CHITOSAN-CURCUMIN AND CHITOSAN-CURCUMIN-
GLYCEROL FILMS: 
4.1.2.1 MECHANICAL ANALYSIS OF THE FILMS: 
 
Figure 4.6 – Mechanical analysis of curcumin-chitosan and curcumin-chitosan-glycerol films 
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Table 4.4 – Toughness and Ultimate bursting strength of composite films 
Sample Area under curve Ultimate bursting 
strength 
Time at bursting 
(sec) 
C control 6023.55 3689.27 4.11 
C10 6064.220 6064.220 3.5 
C50 9534.27 5199.192 5.165 
C100 5057.223 3213.302 4.43 
CG 21773.69 8332.082 6.325 
CG10 17351.233 6831.453 7.3 
CG50 3296.021 2016.275 5 
CG100 4977.348 3227.766 4.43 
 
The area under the curve from figure 4.6a, signifies the toughness of the films. The toughness of 
the films increases with increase in curcumin in the composites. The ultimate bursting strength 
decreased with increasing concentration of curcumin, suggesting curcumin had a role to play in 
the mechanical stability of the films.  
4.1.2.2 XRD AND FTIR ANALYSIS: 
Chitosan has been reported to have diffraction peaks at ~10° and ~20° 2θ and all the composites 
had the characteristic peaks of chitosan in the diffractogram. With increase in concentration of 
the curcumin concentration the amorphous nature of the chitosn increased which is evident with 
the decrease in crystallinity. The FTIR analysis was done to have an understanding about the 
chemical interactions amongst the components of the chitosan-curcumin composite films. The 
major absorption peaks associated with the chitosan include 3428 cm-1 (N-H and O-H 
stretching), 2949 cm-1(CH3 symmetric stretching), 1663 cm
-1 (C=O stretching vibrations), 1439 
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cm-1 (C–N stretching vibration), 1365 cm-1 (CH3 bending vibration), 1134 cm-1 (C–O–C bending 
vibration), and 1084 cm-1 (C–OH stretching vibration). Peak shifts were noticed  around 1439 
cm-1 (C–N stretching vibration), 1365 cm-1 (CH3 bending vibration), 1134 cm-1 (C–O–C bending 
vibration), and 1084 cm-1 (C–OH stretching vibration) suggesting possible interaction of 
curcumin with the chitosan functional groups 
 
Figure 4.7 – FTIR and XRD Spectrographs of chitosan-curcumin, chitosan-curcumin-glycerol 
films 
4.1.2.3 DRUG RELEASE KINETICS OF CURUMIN LOADED CHITOSAN 
COMPOSITE FILMS: 
The drug release of the curcumin loaded chitosan films were carried out as seen in figure-4.8, 
there is steady release of curcumin from the chitosan films. The glycerol-cucumin chitosan films 
showed increase drug release this may be because the glycerol decreased the plasticity of the 
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formed films and the curcumin leached out from the matrix much faster than the chitosan-
curcumin films. Overall there was noticed a steady increase in the release of curcumin. 
 
 
Figure 4.8 – Drug release kinetics of the curcumin-chitosan and curcumin-chitosan-glycerol 
films 
4.1.2.4 HEMO-COMPATABILITY OF CURCUMIN COMPOSITE CHITOSAN FILMS: 
The hemo-compatability of the curcumin-chitosan composite films were done using the goat 
blood and it was found that all the composite films were found to possess a percent hemolysis 
(%Z) which was less than 2. Thus all the films are hemo-compatible and can be successfully 
implied for wound healing applications as wound dressing materials. The Table-4.5 shows the 
hemo-compatibility results 
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Table 4.5 – In vitro-hemo-compatibility test on curcumin-composite films 
 
4.1.2.5 IN VITRO CYTOTOXICITY TEST: 
 
Figure 4.9 - In vitro cyto-compatibility test using MTT for curcumin-chitosan and curcumin-
chitosan-glycerol composite films 
It is seen that the curcumin-chitosan films enhanced the cellular metabolic activity of hADSCs 
and all the films were found to be cyto-compatible. With increase in concentration of curcumin 
concentration the cell viability also increased which proves the usefulness of the fabricated 
composite films can be successfully used as wound dressing material. 
 
A B
Sample OD Readings Mean of 
OD(Dt) 
Z%=(Dt-Dnc)/ 
(Dpc-Dnc)*100 
 R1 R2 R3   
C control 0.225 0.225 0.225 0.225 1.611479 
C 10 0.069 0.070 0.07 0.07 0 
C 50 0.076 0.076 0.076 0.076 0 
C 100 0.161 0.161 0.161 0.161 0.01 
Cg 0.099 0.1 0.1 0.1 0 
Cg10 0.066 0.066 0.066 0.066 0 
Cg50 0.062 0.062 0.063 0.062 0 
Cg100 0.049 0.049 0.049 0.049 0 
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4.1.3 CHARACTERIZATION ALGINATE-CHITOSAN-ECM COMPOSITE FILMS: 
4.1.3.1 MECHANICAL ANALYSIS OF THE ALGINATE-ECM-CHITOSAN FILMS: 
  
S
p
ec
im
en
 4
 
C
h
it
o
sa
n
 a
lg
in
at
e 
E
C
M
 
3
6
.2
4
 
6
0
.4
1
 
2
9
.1
5
 
3
5
5
4
.2
8
8
 
0
.0
1
3
5
6
 
0
.5
8
3
4
8
 
4
9
9
9
6
0
1
3
.2
7
2
 
0
.0
2
8
7
6
 
S
p
ec
im
en
 3
 
C
h
it
o
sa
n
 a
lg
in
at
e 
2
3
.9
9
 
5
9
.9
6
 
2
2
.6
3
 
2
6
6
1
.8
7
9
 
0
.0
0
8
5
5
 
0
.6
8
4
5
0
 
5
8
5
1
3
6
8
3
.0
3
3
 
0
.0
3
3
6
5
 
S
p
ec
im
en
 2
 
al
g
in
at
e
 
1
9
.5
4
 
6
5
.1
3
 
1
7
.3
9
 
4
2
7
0
.9
1
1
 
0
.0
0
5
4
3
 
0
.5
3
9
9
3
 
5
9
5
3
6
1
9
9
.7
3
8
 
0
.0
2
6
6
4
 
S
p
ec
im
en
 1
 
ch
it
o
sa
n
 
2
6
.9
2
 
5
3
.8
4
 
2
0
 
2
9
5
4
.3
3
5
 
0
.0
2
5
1
6
 
1
.7
1
2
9
6
 
4
3
8
6
6
9
9
4
.6
5
9
 
0
.0
8
2
1
8
 
S
p
ec
im
en
 l
a
b
el
 
M
a
x
im
u
m
 L
o
a
d
 
(N
) 
T
en
si
le
 S
tr
en
g
th
 
(M
P
a
) 
L
o
a
d
 a
t 
b
re
a
k
 (
N
) 
Y
o
u
n
g
`s
 M
o
d
u
lu
s 
(M
P
a
) 
E
n
er
g
y
 a
t 
B
re
a
k
 
(S
ta
n
d
a
rd
) 
(J
) 
E
x
te
n
si
o
n
 a
t 
b
re
a
k
  
(s
ta
n
d
a
rd
) 
(m
m
) 
T
ru
e 
S
tr
es
s 
a
t 
b
re
a
k
 (
st
a
n
d
a
rd
) 
(P
a
) 
T
ru
e 
S
tr
a
in
 a
t 
b
re
a
k
 (
st
a
n
d
a
rd
) 
(m
m
/m
m
) 
T
a
b
le
 4
.6
 –
 M
ec
h
a
n
ic
a
l 
A
n
a
ly
si
s 
o
f 
C
h
it
o
sa
n
 A
lg
in
a
te
 E
C
M
 c
o
m
p
o
si
te
 F
il
m
s 
36 
 
 
Figure 4.10 - Mechanical analysis of alginate-chitosan-ECM composite films 
From Table-4.6 it is observed that with incorporation of ECM in the sodium-alginate films the 
ultimate tensile strength and the Young’s modulus of the composite films increased when 
compared to the individual films of chitosan an alginate respectively. The ultimate tensile 
strength was found to be 60.41 MPa and its Young’s modulus is found to be 3554 MPa. 
4.1.3.2 WATER VAPOR TRANSMISSION TEST: 
Water vapor transmission rate (WVTR) is regarded as the transmission of the water vapor per 
unit time through a unit area of the materials under test. The water vapor transmission rate (Table 
4.7) was determined. The differences observed amongst the different groups were statistically 
significant. With incorporation of ECM concentration resulted in the decrease in the WVTR. The 
addition of ECM may result in increase of hydrophobicity and hence resulted in the decrease in 
the permeability of the water vapor from the films.  
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Table 4.7 – Water vapor transmission rate 
SAMPLES WATER VAPOUR TRANSMISSION RATE 
(g/day m2) 
Chitosan control (c) 3.341±1.12 
Sodium Alginate(SA) 4.065±0.45 
SA Chitosan(SAC) 3.358±0.61 
SAC ECM(SACE) 2.686±0.82 
 
4.1.3.3 XRD AND FTIR ANALYSIS: 
 
Figure 4.11 – FTIR and XRD of chitosan-alginate ECM composite films 
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From the FTIR spectrogram, it is observed that the peaks N-H & O-H stretching correspond to 
3435 cm -1, while CH3 symmetric stretch occurs at 2956 cm
-1, the C=O stretching vibration is 
noticed at 1653 cm-1, the C-O-C bending vibration occurs at 1126 cm-1, the Amide I region           
is noticed at 1636-1660 cm-1 and Amide II bands at 1292 cm-1 for proteins. The incorporation of 
ECM in the sodium-alginate films was confirmed with the overlap of amide-I and II spectrsa in 
the composite films. From Figure-4.11, the XRD revealed a broad diffraction pattern at 10° 2θ 
and a characteristic peak at 23° 2θ for chitosan and typical peaks of chitosan in chitosan alginate 
– ECM found at 11.7° and 26.8° 2θ and similarly alginate exhibited a very small crystallinity at 
12°, 23.1°, 31.3°,43.8°. The Crystallinity index for the films was calculated and it is as follows: 
Table 4.8: Crystallinity index of the films 
Samples Crystallinity index 
C 0.285 
SA 0.2343 
SAC 0.1382 
SACE 0.2975 
 
It is noticed that with incorporation of ECM the Crystallinity of the films increased and it is also 
seen from the XRD diffractogram. 
 
4.1.3.4 IN VITRO CYTOTOXICITY TEST: 
 
Figure 4.12 - MTT for chitosan-alginate-ECM composite films 
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All the films were found to be cytocompatible. The presence of ECM showed statistically 
significant increase in cellular proliferation than TCP (Tissue Culture Plate Control). The 
presence of protein 4.1 superfamily in extracellular matrix is known to increase the spreadability 
of the cells through integrin family receptor binding and β-integrin mediated cell spreading [30]. 
The results indicated that the developed composite films were well suited for wound healing 
applications. 
4.2 PREPARATION AND CHARACTERIZATION OF POROUS SCAFFOLD: 
4.2.1 XRD AND FTIR ANALYSIS: 
 
Figure 4.13 – XRD and FTIR analysis of porous scaffolds; sample-1 is ECM, sample-2 is 0.1% 
Chitosan with ECM and sample-3 is 1% chitosan with ECM 
From the FTIR analysis the characteristic peaks of protein and chitosan were found as for Amide 
I region as seen in 1623-1643 cm-1 and Amide-II region between 1553-1578 cm-1 were noticed. 
For chitosan the CH3 symmetric stretching was noticed at 2948 cm
-1 whereas the CH3 
asymmetric bend at 1383 cm-1, C-O-C bending at 1132 cm-1, the CH stretching vibration at 1328 
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cm-1, and the C-OH vibration at 1083 cm-1 were noticed. The successful incorporation of ECM 
was confirmed by the presence of Amide-I and Amide-II band at the composite films. The XRD 
results showed that the Crystallinity of the films decreased with increase in chitosan. The 
Crystallinity index of ECM sample, 0.1% chitosan-ECM and 1% chitosan ECM was found to be 
0.745, 0.709 and 0.683 respectively. 
4.2.2 SCANNING ELECTRON MICROSCOPY: 
From Figure-4.14-B the presence of fat was noticed. If the porous ECM scaffold were washed 
with 0.5% SDS to remove fat, a better morphology of the scaffold can be obtained.  
 
Figure 4.14 – SEM Micrographs representing presence of fat in porous ECM scaffold 
From figure-4.15, it is observed that with increase in the chitosan concentration in the ECM-
Chitosan composite scaffolds, the pore size gradually decreased. This is evident from the SEM 
micrographs and obviously chitosan plays a crucial role in controlling the porosity and the pore 
size of the freeze dried scaffold. 
 
Figure 4.15 – SEM micrographs of composite porous scaffolds; sample-1 is ECM, sample-2 is 
0.1% Chitosan with ECM and sample-3 is 1% chitosan with ECM 
A B
A B C
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   4.2.3 IN VITRO CYTOTOXICITY TEST: 
 
Figure 4.16 – MTT assay for ECM, 0.1% Chitosan with ECM and 1% chitosan with ECM 
porous scaffolds 
All the samples were found to be cytocompatible. For all samples statistically significant 
increase in cellular proliferation (p <0.01) when compared to the TCP (Tissue culture plate 
control) was noticed. No statistical significant difference(p<0.01) in cellular proliferation 
between ECM and ECM+0.1% chitosan was observed. There was however statistical 
significant increase (p<0.01) in cellular proliferation in ECM+1% Chitosan when compared 
with ECM+0.1%Chitosan porous scaffold. 
4.3 OPTIMIZATION OF PARAMETERS AND CHARACTERIZATION OF 
ALGINATE-ECM MICROBEADS: 
4.3.1 OPTIMIZATION OF PARAMETERS: 
Optimized parameters by taking the consideration of needle length between tip of the needle 
to the calcium chloride solution and at 3 % concentration of alginate, at different rpm. 
Finally, the optimized parameters at 1000 rpm in 15 ml falcon tube by taking 100 µm of 
calcium chloride with 0.1 % tween 80 at 3 % concentraion of alginate.  
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Figure 4.17 – Optimized parameters and observed through optical microscopy  
 A– with needle length, B-with 3000 rpm, C- with 2000 rpm 
All these morphology through optical microscopy, the microbeads are not forming with the 
taylor cones and overlapping with each other. 
 
Figure 4.18 – Optical microscope Image of sodium alginate ECM beads at 1000 rpm 
4.3.2 CONFOCAL MICROSCOPY : 
The ECM can be detected by ANS (8-Annilino-napthalene sulfate ) and observed that ECM 
can be incorporated into the micro beads and it is spherical. 
 
Figure 4.19 –Confocal Microscopy Images of Sodium alginate ECM composite beads 
 
A B C
A B 
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4.3.3 SCANNING ELECTRON MICROSCOPY: 
 
Figure 4.20 SEM Images of dried sodium alginate ECM composite beads. 
The SEM results proved that ECM content can be within the beads even after drying of 
beads. In SEM analysis, observed that micro ridges and valleys which enhances the surface 
area. 
4.3.4 X- RAY DIFFRACTION: 
 
Figure 4.21 : Analysis of XRD pattern of sodium alginate ECM composite microbeads 
The XRD analysis of sodium alginate ECM composite microbeads showed that the 
crystallinity index is 0.37813. According to literature review, found that the pure collagen 
and alginate execute broad peaks at 10°, 23° 2θ and the strong peak formation broaden due to 
introduction of ECM to alginate beads. It indicates increase in amorphous nature and 
decrease in crystallinity. 
 
  
A B 
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4.3.5 IN VITRO CYTOTOXICITY TEST: 
 
Figure 4.22 : MTT assay of Sodium alginate ECM composite beads. 
The beads were found to be cytocompatible. There is statistically significant increase in 
cellular proliferation when compared to the TCP (Tissue culture plate control) was noticed. 
4.4 OPTIMIZATION OF ECM COMPOSITE NANOFIBERS: 
4.4.1 ECM – PVA ELECTROSPINNING OPTIMIZATION : 
Electrospinning carried out in roller electrode electrospinning with the rpm range between 1-
16 by varying the concentration of ECM in different solvents like distilled water, acetic acid 
(varying concentration) and NAOH (varying concentration) found that it is not 
electrospinnable. Later, tried with varying concentrations of both ECM and PVA (Poly 
Vinyl Alcohol) and by taking  10 % of PVA with varying concentration of SDS (Sodium 
Dodecyl Sulfate). 
It was found that the solution is electrospinnable at 100 mg/ml with 10 % PVA and SDS at 
the concentration of 0.02 %. 
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Table 4.9 : Optimizing the ECM PVA to generate fibers 
Sl 
No. 
Solute Solvent Outcome 
1 ECM(Varying 
conc.) 
DW Not electrospinnable 
2 ECM(Varying 
conc.) 
Acetic 
acid(varying 
conc.) 
Not electrospinnable 
3 ECM(Varying 
conc.) 
NaOH(varying 
conc.) 
Not electrospinnable 
4 ECM(Varying 
conc.) + 
PVA(Varying 
conc.)  
DW Not electrospinnable 
5 ECM(100 mg/ml) + 
PVA(10% ) + less 
than 0.02% SDS 
DW Not electrospinnable 
6 ECM(100 mg/ml) + 
PVA(10% ) + 
0.02% SDS or more 
DW Electrospinnable 
 
Taking the optimized parameter in distilled water, tried with different distances between the 
sample and the collector at different voltage, at rpm 12 and measured the thickness. 
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Table 4.10 : Electrospinning with ECM-PVA in optimized parameter. 
Sl 
No. 
Distance 
(cm) 
Voltage(kV) Outcome Thickness(nm) 
1 11 < 45 Not 
Electrospinnable 
- 
2 11 ≥45 Electrospinnable 375 ±56 
3 12 ≥45 Electrospinnable 225 ±25 
4 13 <50 Not 
Electrospinnable 
- 
5 13 ≥50 Electrospinnable 260±47 
6 14 ≥50 Electrospinnable 235±39 
7 15 ≥50 Electrospinnable 243±43 
8 16 <55 Not 
Electrospinnable 
- 
9 16 ≥55 Electrospinnable 198±28 
10 17 ≥55 Electrospinnable 213±56 
11 18 ≥55 Electrospinnable 235±65 
12 19 ≥55 Electrospinnable 527±84 
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Finally, optimized with the less thickness of fibers at 16 cm of distance at greater than or 
equal to 55 kV which is electrospinnable. 
4.4.2 CHITOSAN ECM PVA ELECTROSPINNING OPTIMIZATION: 
To exclude the SDS, tried with the chitosan – ECM – PVA composites electrospinning in the 
solvent of 0.5 M acetic acid. 
Table 4.11 : Optimizing with ECM Chitosan PVA in acetic acid solvent. 
Sl 
No. 
Solute Solvent Outcome 
1. ECM(100 
mg/ml)+PVA(10%) 
0.5M acetic 
acid 
Not 
Electrospinnable 
2 {ECM(100 
mg/ml)+PVA(10%) } : 
Chitosan (1%)=In varying 
ratio 
0.5M acetic 
acid 
Not 
Electrospinnable 
3 {ECM(100 
mg/ml)+PVA(10%) } : 
Chitosan (2%) =  ≤ (40:60) 
0.5M acetic 
acid 
Not 
Electrospinnable 
4 {ECM(100 
mg/ml)+PVA(10%) } : 
Chitosan (2%) =   30:70 
0.5M acetic 
acid 
Electrospinnable 
5 {ECM(100 
mg/ml)+PVA(10%) } : 
Chitosan (2%) =  ≥ (20:80) 
0.5M acetic 
acid 
Not 
Electrospinnable 
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Finally, the composite with chitosan at the concentration of 100 mg/ml of ECM, 10 % of 
PVA and at concentration of 2 % chitosan in 30 : 80 ratio nanofibers were obtained. 
By taking the above optimized parameter, tried at different distances and voltages to obtain 
less thickness of fibers. 
Table 4.12: Optimizing working distance for nanofiber generation 
Distance 
(cm) 
Voltage(kV) Outcome Thickness 
(nm) 
11 <55 Not Electrospinnable - 
11 ≥55 Electrospinnable 544±57 
13 <55 Not Electrospinnable - 
13 ≥55 Electrospinnable 356±65 
15 <55 Not Electrospinnable - 
15 ≥55 Electrospinnable 410±48 
17 <60 Not Electrospinnable - 
17 ≥60 Electrospinnable 586±76 
 
At the working distance of 13 cm and the working voltage at greater than or equal to 55 
obtained less thickness of nano fibers. 
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4.4.3 SCANNING ELECTRON MICROSCOPY: 
     
Figure 4.23 : SEM Micrographs of nano fibers with ECM PVA composite. 
          A: PVA-SDS-ECM:11 cm                                    E: PVA-SDS-ECM:15 cm       I : PVA-SDS-ECM:19 cm 
          B: PVA-SDS-ECM:12 cm                                    F: PVA-SDS-ECM:16 cm      
          C: PVA-SDS-ECM:13 cm                                   G: PVA-SDS-ECM:17 cm 
          D: PVA-SDS-ECM:14 cm                                  H: PVA-SDS-ECM:18 cm 
The Electrospinning with PVA-SDS-ECM nanofibers obtained with less thickness at 16 cm of 
working distance. 
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Figure 4.24 : SEM micrographs of nanofibers with chitosan – ECM – PVA composite. 
A : Chitosan-PVA-ECM (11 cm- 55kV) 
B : Chitosan-PVA-ECM (13 cm- 55kV) 
C : Chitosan-PVA-ECM (15 cm -55 kV) 
D : Chitosan-PVA-ECM (17 cm - 60kV) 
The electrospinning of ECM-PVA- chitosan nanofibers obtained with less thickness at working 
distance of 13 cm. 
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CHAPTER-5 
 
 
 
CONCLUSION  
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The present study reports the preparation and characterization of the human derived ECM and 
chitosan composite films, chitosan ECM porous scaffolds, ECM PVA chitosan nanofibers and 
sodium alginate chitosan ECM beads. An increase in the chitosan content resulted in decrease in 
pore size and crystallinity of porous scaffolds. Alginate beads with ECM can be prepared for soft 
tissue engineering within 250 µm, at 1000 rpm. Nanofibers can be formed with less thickness by 
optimizing the parameters of chitosan ECM PVA in acetic acid.  An increase in the ECM content 
resulted in the increase in the hydrophilicity of the films. This, in turn, was found to improve the 
moisture retention capacity and prevent the evaporation of water. This is important in wound 
healing. Excessive evaporation of water results in the drying of the wound surface, which 
subsequently results in the decrease in the biosynthetic reactions occurring at the wound surface. 
This consequently results in the decrease in the wound healing rate. The mechanical studies 
suggested that the films with higher proportions of ECM (within the experimental compositions) 
may be more efficient as wound dressing materials. The presence of ECM did not alter the 
hemolysis significantly. Though metabolic assay results indicate decrease in cell proliferation in 
presence of ECM, the metabolic assay indices are still quite higher than the petri dishes (control). 
The preliminary study suggested a positive sign that the ECM based composites along with 
chitosan may be tried as wound dressing materials. In future, the efficacy of the human ECM and 
the composite films will be evaluated in chronic wounds in vivo. 
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